Pursuant to the provision of title 42 Sections 431.408 of the Code of Federal Regulations, a public notice is required for a 1115 waiver that includes one or more substantive changes.
Public Notice: Substance Use Disorder Treatment Demonstration Waiver
||The purpose of this posting is to receive public input on the Substance Use Disorder Treatment Demonstration Waiver Proposal prior to submission to the Centers for Medicare and Medicaid Services (CMS).
||Substance Use Disorder Treatment Demonstration Waiver
The Demonstration waiver proposal may be viewed at the Ohio Department of Medicaid and at the "Detail" link above.
Comments must be submitted by midnight of the comment period end date using one of the following options:
Public Hearing Information
ODM will host public hearings on the proposed Substance Use Disorder Treatment Demonstration Waiver Proposal at the following dates, times, and locations:
- November 15, 2018 at 2:00 pm at the Medical Care Advisor Committee, Ohio Department of Medicaid, 50 W. Town Street, Columbus Ohio 43215. Comments can be received during the meeting by telephone at 614-752-2375.
- November 20, 2018 at 1:00 at Paramount, 1901 Indian Wood Circle, Maumee, Ohio 43537
Written testimony, in addition to oral testimony, is encouraged.
Written comments sent to:
Attn: Substance Use Disorder Treatment Demonstration Waiver
Bureau of Health Plan Policy
Ohio Department of Medicaid
50 W. Town Street, Suite 400
Columbus, OH 43215
FAX:(614)995-1301 (please include Attn: Substance Use Disorder Treatment Demonstration Waiver in the subject line)
In-person:Courier or in-person submission to Attn: BHPP, Lazarus Building, 50 W. Town St., Columbus OH 43215